Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence, Chronic inflammatory demyelinating polyradiculoneuropathy, Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue, Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria, Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying, Good Practice Points for defining diagnostic criteria for CIDP-initial management, Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence), Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks, No evidence-based guideline-as none of trials, systematically assessed long-term management, Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres
dx.doi.org/10.1002/9781444328394.ch20, hdl.handle.net/1765/90459
Erasmus MC: University Medical Center Rotterdam

van den Bergh, P.Y.K, Hadden, R.D.M, Bouche, P, Cornblath, D.R, Hahn, A, Illa, I, … van Schaik, I.N. (2010). Chronic Inflammatory Demyelinating Polyradiculoneuropathy. doi:10.1002/9781444328394.ch20